Gene therapy injection aims to lower eye pressure in glaucoma
Disease control
Recruiting now
This early study tests a new gene therapy called GVB-2001 for people with primary open-angle glaucoma. The treatment is given as an injection into the eye to help lower high pressure inside the eye. About 6 adults aged 18 to 75 with glaucoma for at least a year will take part. Th…
Phase: PHASE1, PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC